A primary or metastatic malignant neoplasm affecting the thyroid gland. ICD-10-CM C73 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
Thyroid cancer metastatic to unspecified site. Clinical Information. A primary or metastatic malignant neoplasm affecting the thyroid gland. ICD-10-CM C73 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc.
1 Z08 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Encntr for follow-up exam after trtmt for malignant neoplasm 3 The 2021 edition of ICD-10-CM Z08 became effective on October 1, 2020. More items...
Diagnosis Index entries containing back-references to C73: Adenocarcinoma - see also Neoplasm, malignant, by site follicular with papillary C73 Carcinoma (malignant) - see also Neoplasm, by site, malignant C cell unspecified site C73 Goiter (plunging) (substernal) E04.9 ICD-10-CM Diagnosis Code E04.9 Hurthle cell adenocarcinoma C73
E89. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E89.
ICD-10 code Z85. 850 for Personal history of malignant neoplasm of thyroid is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
R94. 6 - Abnormal results of thyroid function studies | ICD-10-CM.
ICD-10 C73: Papillary thyroid ca.
Z85. 850 - Personal history of malignant neoplasm of thyroid. ICD-10-CM.
In-active neoplasm or cancer is coded when a patient is no longer receiving treatment for cancer and the cancer is in remission by using the V “history of” code (“Z” code for ICD-10).
ICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
6: Abnormal results of thyroid function studies.
E04. 1 - Nontoxic single thyroid nodule | ICD-10-CM.
9: Fever, unspecified.
Total thyroidectomy involves the removal of the entire thyroid gland. This procedure is most often performed to treat thyroid cancer, but it may also be performed to treat uncontrollable hyperthyroidism or goiter that causes severe symptoms.
ICD-10 Code for Atherosclerotic heart disease of native coronary artery without angina pectoris- I25. 10- Codify by AAPC.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A primary or metastatic malignant neoplasm affecting the thyroid gland.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
When an encounter is for a pathological fracture due to a neoplasm, and the focus of treatment is the fracture, a code from subcategory M84.5, Pathological fracture in neoplastic disease, should be sequenced first, followed by the code for the neoplasm.